Zinbryta (Daclizumab) for Multiple Sclerosis

On March 2, 2018, manufacturers Biogen and AbbVie announced that they were withdrawing Zinbryta (Daclizumab) from the market worldwide. The drug is no longer available.

For more details about this treatment, visit:
Biogen and AbbVie Announce the Voluntary Worldwide Withdrawal of Marketing Authorizations for ZINBRYTA (daclizumab) for Relapsing Multiple Sclerosis - Biogen
http://media.biogen.com/press-release/autoimmun...

Join today!

Information You Can Trust.
Support When You Need It.

Continue with Facebook

Continue with Google

By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data Policy and Privacy policies.Your privacy is our priority

Already a Member? Log in

MyMSTeam is the social network for those living with multiple sclerosis. Get the emotional support you need from others like you, and gain practical advice and insights on managing treatment or therapies for multiple sclerosis. MyMSTeam is the only social network where you can truly connect, make real friendships, and share daily ups and downs in a judgment-free place.

MyMSTeam is not a medical referral site and does not recommend or endorse any particular provider or medical treatment.
No information on MyMSTeam should be construed as medical and/or health advice.

Your Privacy is Our Priority

Manage Cookies

Connect with others who understand.

Zinbryta (Daclizumab) for Multiple Sclerosis

Join today!

Information You Can Trust.Support When You Need It.

Information You Can Trust.
Support When You Need It.